Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Dermatologists are more accurate than general practitioners in diagnosing skin conditions, especially skin cancer.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Promising cancer treatments were found, but the manufacturer closed.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Flexible bioelectronics show promise in non-invasive cancer detection and treatment but need improvements in stability and effectiveness.

Sorafenib often causes skin side effects, indicating effective cancer treatment.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

Multiphoton microscopy can effectively assess breast cancer treatment responses without labels.

High-frequency ultrasonography is a useful but underused tool in dermatology for assessing skin cancers, monitoring diseases, and evaluating treatments.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

Fish cell spheroids are a promising tool for replicating real-life conditions in research.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Stem cells control their future role by changing ERK signal timing, affecting tissue regeneration and cancer.

Caffeine boosts alertness, helps breathing, acts as a diuretic, and may aid cancer treatment.

Scalp cooling is an effective and safe way to prevent hair loss from chemotherapy, with manageable side effects and low risk of scalp cancer.

Sorafenib can cause a unique skin reaction.

Cutaneous vesicostomy and cystoscopic valve ablation both have pros and cons for managing posterior urethral valves.

Sorafenib may cause hand-foot and stump syndrome, requiring early detection and management.

The patient's hypothyroidism improved with medication adjustments and careful management.

Managing malignant ureteral obstruction is challenging and requires personalized treatment to protect kidney function and patient health.